Honoring The Bond Of A LifetimeApril 17, 2009 Aging is an inevitable and normal process of living. It should not be considered a disease. Aging is expressed as physical weakening, reduced stamina and deterioration of the organs and connective tissues in the body. It is associated with gradual changes in the body's phenotype the entire physical, biochemical and physiological makeup of an individual as determined both genetically and environmentally. Changes such as wrinkles in the skin and gray hair are due to the normal phenomenon of cellular senescence, the process of growing old. Many diseases, including cancer, involve a multi-step process that accumulates genetic damage over time. As our pets enjoy a longer lifespan, their bodies provide the time needed for the expression of senescence, disease and cancer. Living Long The human-animal bond grows stronger with the passing of time. People are very proud of their older pets and they want them to live as long as possible in good health. One of the biggest fears of caregivers of senior pets is that their pet will get cancer. The most common concurrent problems afflicting older pets are arthritis, dermatitis, dental disease, endocrinopathies, organ failure and obesity. The dilemma for caregivers …
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
Pfizer Animal Health Acquires EmbrexApril 17, 2009 Pfizer Animal Health has completed its acquisition of Embrex Inc., an international agricultural biotechnology company known for its Inovoject vaccine-delivery systems. The transaction has an aggregate equity purchase price of about $155 million. Embrex, which is now a wholly-owned subsidiary of Pfizer, will continue to be based in Raleigh-Durham, N.C. Embrex common stock is no longer publicly traded and was de-listed from NASDAQ as the close of the market on Jan. 19.
Psittacosis Concerns Suspend Bird Sales At Petsmart StoresApril 17, 2009 Petsmart temporarily suspended bird sales at 775 of its stores in 46 states due to ongoing concerns of a bacteria infection that sickened at least 22 of its birds as well as several birds at a Petland in Minnesota and quarantined birds at a Superpetz in Georgia. Routine testing of more than 500 birds in Petsmarts across the country revealed psittacosis in 20 cockatiels, one finch and one parakeet. The retailer, on Dec. 19, 2007, temporarily suspended bird sales at any of its stores that received birds from a single vendor, Preferred Birds of Milton, Fla., according to Jennifer Simmons, a spokesperson for Petsmart. During the temporary sale suspension, Petsmart is treating all of the birds that might have been exposed to the bacteria with antibiotic-treated feed, Simmons said. Employees are also using masks, gloves and protective gowns before entering bird areas. "Most of this is just precautionary," Simmons said. Although the birds remain in their aviaries in the stores, they are enclosed in glass and signs tell the public they are not for sale, Simmons said. The state of Georgia wanted the precautions to go further, moving the birds away from the public, so …
Financial Newswire 08-27-2007April 17, 2009Abaxis Inc. Abaxis Inc.’s veterinary division reported revenue of $16.4 million for its first quarter ended June 30, compared to revenue of $15.5 million in the year-ago period. During the quarter, the company sold more than 1.1 million medical and veterinary reagent discs, an increase of 19 percent, compared to 957,000 medical and veterinary reagent discs in the year-ago period. Overall, Abaxis, of Union City, Calif., reported net income of $3.1 million on revenue of $22.9 million for its first quarter, compared to net income of $2.4 million on revenue of $20.4 million in the year-ago period. Eli Lilly Co. Eli Lilly Co.’s animal health products had worldwide sales of $214.7 million for its second quarter ended June 30, an increase of 7 percent compared to the year-ago period. Overall, Eli Lilly, of Indianapolis, reported net income of $663.6 million on revenue of $4.6 billion for its second quarter, compared to net income of $822 million on revenue of $3.9 billion in the year-ago period. Year to date, the company reported net income of $1.2 billion on revenue of $8.9 billion, compared to net income of $1.7 billion on revenue of $7.6 billion in the year-ago period. Neogen …
West Nile DNA Vaccine Available For HorsesApril 17, 2009 Fort Dodge Animal Health of Overland Park, Kan., has launched a vaccine for horses to aid in the prevention of viremia caused by the West Nile virus. The company, which worked in collaboration with the U.S. Centers for Disease Control and Prevention, says its West Nile-Innovator DNA is the first DNA vaccine fully licensed by the U.S. Department of Agriculture. The vaccine uses purified DNA plasmids to stimulate an immune response, unlike conventional vaccines that rely on the foreign proteins derived from disease-causing agents. It contains no live or killed viruses, no live vector or viral proteins, and there is no risk of reversion to virulence, according to Fort Dodge Animal Health. The vaccine provides a 12-month duration of immunity after two initial doses, and according to field safety studies of 645 male and female horses of various breeds and ages, it is greater than 99 percent reaction-free. Annual revaccination requires one dose. The product will be sold only to veterinarians, who are required to sign a user compliance agreement indicating they will use the vaccine within their practice if an established veterinarian-client-patient …
PetMed Express Posts Sharp Profit Growth For 2008April 17, 2009 PetMed Express Inc. of Pompano Beach, Fla., reported its net income increased 39 percent and revenues increased 16 percent for its fiscal year ended March 31. “We are pleased to report high profitability for the year, which can be attributed to our strong reorder growth and our success in leveraging operating expenses,” said Mendo Akdag, PetMed’s chief executive officer and president. “Our focus in fiscal 2009 will be on capturing additional market share and improving reorders and our customer service levels.” Both reorder sales and Internet sales, which are less expensive for the company, outpaced its overall growth for the year. For 2008, the company saw reorder sales increase 22 percent to $134.3 million, about 71 percent of its $188.3 million in overall sales. Internet sales grew 21 percent to $122.5 million (about 65 percent of overall sales). During the year, PetMed acquired 710,000 new customers, up from 681,000 in fiscal 2007. “We have agreed to extend our current lease for our corporate headquarters until 2012 and have added another 15,000 square feet, primarily for the extension of our warehouse and pharmacy operations, in order to support our future growth,” Akdag said. For …
Diamond Recalls Dog Food Due To Cross-ContaminationApril 17, 2009 Diamond Pet Foods of Meta, Mo., recalled some of its 40-pound bags of Nutra Nuggets Lamb Meal and Rice Formula dry dog food because of cross-contamination with melamine-tainted rice-protein concentrate used to make other products at its Lathrop, Calif., facility. Only bags with production codes NLR0404A2SL and NLR0404B2SL with a “best before” date of Oct. 9, 2008, are being recalled. The contaminated product was distributed to retailers in Arizona, California, Nevada, Oregon, Washington and British Columbia, Canada. No other Nutra Nugget products are affected and no dog deaths have been reported at this time, Diamond said. Products can be returned to the store where they were purchased for a full refund. Diamond has also set up an information hotline for pet owners at (866) 214-6945. It is open Monday through Saturday from 8 a.m. to 7 p.m. CDT. <HOME>
Dr. Dodman To Teach Canine Aggression Seminar In MaineApril 17, 2009 Happy T犀利士 ails Dog Studio of Portland, Maine, will be hosting a Canine Aggression Seminar—the first in an ongoing series of dog training events with animal behavior professionals—on March 29 from 9 a.m. to 4 p.m. at its Bishop Street training facility. The seminar, open to veterinarians, veterinary technicians, trainers, shelter workers and dog owners, will be taught by Nicholas Dodman, BVMS, Dipl. ACVB, Dipl. ACVA, professor, section head and program director at the Animal Behavior Department of Clinical Sciences at Tufts’ Cummings School of Veterinary Medicine. Dr. Dodman will cover the various types of aggression and respective prevention and management, including fear-based conditions, compulsive behaviors, medical causes and behavioral medications. Continuing education units are available for veterinarians and veterinary technicians. The seminar is being sponsored by Portland-based Planet Dog. The company’s flagship initiative is the Planet Dog Foundation, which receives a percentage of every Planet Dog purchase, including toys, collars and treats. In turn, the money is donated back to nonprofit canine service programs nationwide. Happy Tails Dog Studio also includes daycare, boarding and a day spa. For registration fees and details, visit
Human-Animal Bond Proposals SoughtApril 17, 2009 The American Assn. of Human-Animal Bond Veterinarians and the Waltham Center for Pet Nutrition in the United Kingdom have issued a joint call for research proposals in the area of human-animal interactions. The groups suggest particular interest in the impact of pets on the physical well-being of children, the role of pets in the lives of elders and the impact of culture on the human-animal bond. A grant of up to $20,000 will be awarded. Entry deadline is Sept. 1. Research must be completed within two years of receiving the award. For more information, visit www.aahabv.org. <HOME>
Vivalis And Fort Dodge Reach Vaccine AgreementApril 17, 2009 Vivalis and Fort Dodge Animal Health have signed a commercial license to use the EB66 cell line, derived from duck embryonic stem cells, for the production of several veterinary vaccines. The cell line is a product of Vivalis, a French biopharmaceutical company that provides cell-based solutions to the pharmaceutical industry for the manufacture of vaccines and proteins, and develops drugs for the prevention and treatment of viral diseases. “Vivalis is pleased to enter in this new commercial agreement with one of the major players in this field,” said Frank Grimaud, chief executive officer of Vivalis. “This agreement confirms that our EB66 cell line is a very attractive alternative to embryonated eggs for the industrial production of viral vaccines both for human and animal health.” Steve Chu, DVM, Ph.D., executive vice president of animal health research and development at Fort Dodge Animal Health, said: “This collaboration demonstrates Fort Dodge’s continuous commitment to evaluate and utilize novel technology, which may offer several potential advantages over conventional methods for the development and manufacture of biologics for animal health.” Terms of the agreement were not disclosed. Fort Dodge Animal Health, a division …
